checkAd

    EANS-Adhoc  314  0 Kommentare Semperit AG Holding / Semperit postpones publication of the interim Group report for third quarter: examination of a potential impairment loss at Sempermed

    --------------------------------------------------------------------------------
    Disclosed inside information pursuant to article 17 Market Abuse Regulation
    (MAR) transmitted by euro adhoc with the aim of a Europe-wide distribution.
    The issuer is responsible for the content of this announcement.
    --------------------------------------------------------------------------------

    Quarterly Report
    13.11.2019

    Vienna - Austria, 13 November 2019 - Based on the current insights of the
    Executive Board of the Semperit AG Holding into the competitive environment of
    the medical business, a significant impairment loss might occur in the Medical
    Sector (Sempermed segment).

    The publication of the interim Group report as of 30 September 2019, which was
    planned for 21 November 2019, will be postponed; the new date will be announced
    separately. On 21 November 2019, a shortened reporting will be presented.




    Further inquiry note:
    Monika Riedel
    Director Group Communications & Sustainability
    +43 676 8715 8620
    monika.riedel@semperitgroup.com


    Judit Helenyi
    Head of Investor Relations
    +43 676 8715 8310
    judit.helenyi@semperitgroup.com





    end of announcement euro adhoc
    --------------------------------------------------------------------------------

    issuer: Semperit AG Holding
    Modecenterstrasse 22
    A-1030 Wien
    phone: +43 1 79 777-310
    FAX: +43 1 79 777-602
    mail: judit.helenyi@semperitgroup.com
    WWW: www.semperitgroup.com
    ISIN: AT0000785555
    indexes: ATX PRIME, WBI, ATX GP
    stockmarkets: Wien
    language: English





    Diskutieren Sie über die enthaltenen Werte



    news aktuell
    0 Follower
    Autor folgen

    Verfasst von news aktuell
    EANS-Adhoc Semperit AG Holding / Semperit postpones publication of the interim Group report for third quarter: examination of a potential impairment loss at Sempermed - Disclosed inside information pursuant to article 17 Market Abuse Regulation (MAR) transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. - Quarterly Report …